移至標頭
移至導覽
移至內部
移至註腳
登入
幫助
English
研究資源
CUHK UPDates
論文庫
專家名錄
使用指引
關於我們
研究人員名單
> Assistant Professor Chi Hang WONG
主頁
研究成果
研究人員專頁
學系學部專頁
研究範圍
黃智博士
個人資料
中大研究成果
Paclitaxel Induces Immunogenic Cell Death in Ovarian Cancer via TLR4/IKK2/SNARE-Dependent Exocytosis
(
2020
)
Phthalaldehyde-Amine Capture Reactions for Bioconjugation and Immobilization of Phthalocyanines
(
2020
)
Targeting the polycomb repressive complex-2 related proteins with novel combinational strategies for nasopharyngeal carcinoma
(
2020
)
Embedding of Genes Using Cancer Gene Expression Data: Biological Relevance and Potential Application on Biomarker Discovery
(
2019
)
Intratumoural MDSC recruitment by chemotherapeutic agent, 5-FU offsets the anti-tumor activity of immune-checkpoint inhibitor in HCC
(
2019
)
Role of polycyclic aromatic hydrocarbons as a co-factor in human papillomavirus-mediated carcinogenesis
(
2019
)
Genomic analysis of liver cancer unveils novel driver genes and distinct prognostic features
(
2018
)
Preclinical evaluation of ribociclib and its synergistic effect in combination with alpelisib in non-keratinizing nasopharyngeal carcinoma
(
2018
)
A preclinical study of the combined treatment of arginase and canavanine in pancreatic cancer
(
2017
)
Preclinical study on the efficacy of Panobinostat (LBH589) in hepatocellular carcinoma (HCC)
(
2017
)
Low expressions of ASS1 and OTC in glioblastoma suggest the potential clinical use of recombinant human arginase (rhArg)
(
2016
)
A Phase II Study of Axitinib in Patients With Recurrent Or Metastatic Nasopharyngeal Carcinoma (NPC)
(
2015
)
Chemotherapeutic Drug, Paclitaxel, Induces the Key Molecular Determinants of Immunogenic Cell Death in Ovarian Cancer
(
2015
)
ESTABLISHING THE ROLE OF ARGININE DEPRIVATION WITH THE RECOMBINANT HUMAN ARGINASE PEG-BCT-100 IN THE TREATMENT OF ADULT GLIOMAS
(
2015
)
Preclinical evaluation of afatinib (BIBW2992) in esophageal squamous cell carcinoma (ESCC)
(
2015
)
Preclinical evaluation of PI3K inhibitor BYL719 as a single agent and its synergism in combination with cisplatin or MEK inhibitor in nasopharyngeal carcinoma (NPC)
(
2015
)
Preclinical Evaluation of Recombinant Human Arginase PEG-BCT-100 leading to Arginine Deprivation in Gliomas
(
2015
)
Preclinical Evaluation of the Recombinant Human Arginase PEG-BCT-100 leading to Arginine Deprivation in Gliomas
(
2015
)
Preclinical Evaluation of the Recombinant Human Arginase PEG-BCT-100 leading to Arginine Deprivation in Sarcomas
(
2015
)
Preclinical Evaluation of the Recombinant Human Arginase PEG-BCT-100 leading to Arginine Deprivation in Sarcomas
(
2015
)
preclinical study of afatinib in esophageal squamous cell carcinoma (ESCC)
(
2015
)
Targeting angiogenic genes as a therapeutic approach for hepatocellular carcinoma
(
2015
)
Targeting Angiogenic Genes as a Therapeutic Approach for Hepatocellular Carcinoma
(
2015
)
The Mechanistic Study on the Effect of Platinum-based Chemotherapy Efficacy Imposed by EGFR-TKI Regulated ERCC1 in Non-small Cell Lung Cancer (NSCLC)
(
2015
)
Down-Regulation of ERCC1 by EGFR-TKI Improves Platinum-Based Chemotherapy Efficacy for Non-Small Cell Lung Cancer (NSCLC), 26-29 March 2014, Geneva, Switzerland
(
2014
)
Manipulation and Detection of Circulating Tumor Cells on a Microfluidic Device
(
2014
)
Mechanistic study of acquired cisplatin resistance in esophageal squamous cell carcinomas (ESCC)
(
2014
)
Preclinical evaluation of PI3K inhibitor BYL719 as a single agent and its synergism in combination with cisplatin or MEK inhibitor in nasopharyngeal carcinoma (NPC) using 3D cell culture system
(
2014
)
Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models
(
2014
)
Preclinical study of afatinib (BIBW2992) in nasopharyngeal carcinoma (NPC)
(
2014
)
The Preclinical Efficacy of a Novel PI3K-α Inhibitor, BYL719, in Nasopharyngeal Carcinoma (NPC)
(
2014
)
Enhanced Antitumor Activity with Combining Effect of mTOR Inhibition and Microtubule Stabilization in Hepatocellular Carcinoma
(
2013
)
Enhanced Antitumor Activity with Combining Effect of mTOR Inhibition and Microtubule Stabilization in Hepatocellular Carcinoma
(
2013
)
Manipulation and Detection of Cancer Tissues on a Microfluidic Deice
(
2013
)
Manipulation and Detection of Cancer Tissues on a Microfluidic Device
(
2013
)
Preclinical evaluation of combined TKI-258 and RAD001 in hepatocellular carcinoma
(
2013
)
Preclinical evaluation of PF-04691502 in nasopharyngeal carcinoma (Abstr No. 2100)
(
2013
)
Preclinical evaluation of the AKT inhibitor MK-2206 in nasopharyngeal carcinoma cell lines
(
2013
)
Preclinical evaluation of the PI3K-mTOR dual inhibitor PF-04691502 as a novel therapeutic drug in nasopharyngeal carcinoma
(
2013
)
In Vivo FRET Imaging Revealed a Regulatory Role of RanGTP in Kinetochore-Microtubule Attachments via Aurora B Kinase
(
2012
)
Orally active peptidic bradykinin B 1 receptor antagonists engineered from a cyclotide scaffold for inflammatory pain treatment
(
2012
)
Preclinical activity of axitinib and its associated change of serum biomarkers in nasopharyngeal carcinoma (NPC)
(
2012
)
Preclinical Evaluation of Combined TKI258 and RAD001 in Hepatocellular Carcinoma
(
2012
)
Preclinical evaluation of the AKT inhibitor MK2206 in nasopharyngeal carcinoma cell lines
(
2012
)
Significance of survivin subcellular localization and splice variants expression in nasopharyngeal carcinoma (NPC): Implication in re-sensitizing cisplatin resistant cell to treatment
(
2012
)
The LIM-only protein FHL2 regulates interleukin-6 expression through p38 MAPK mediated NF-kappa B pathway in muscle cells
(
2012
)
The role of targeting mTOR in enhancing chemosensitivity in hepatocellular carcinoma
(
2012
)
Expression of SARS-coronavirus spike glycoprotein in Pichia pastoris
(
2009
)
A Method to Visualize Exhaled Aerosols Produced During the use of Oxygen Masks using Optical Flow
(
2006
)
分享連結
上次更新時間 2019-16-08 於 06:53
分享連結
您的名稱*
您的電子郵件*
收件者名稱*
收件者電子郵件*
訊息
Auxilliary Information
不會儲存任何資訊或與任何第三方分享資訊。
Cancel
Our policy towards the use of cookies
All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Ok to Continue
Cookie Policy
